BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8615621)

  • 1. Expression of cytokeratin 8 in basal cell carcinoma: a comparative immunohistochemical and immunoelectron microscopy study.
    Kooy AJ; Tank B; de Jong TA; Vuzevski VD; Bosman FT; van Joost T
    Anticancer Res; 1996; 16(1):277-82. PubMed ID: 8615621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of cytokeratin 8 and low molecular weight cytokeratins in human basal cell carcinoma.
    Kooy AJ; Tank B; Vuzevski VD; Van Joost T
    Anticancer Res; 1995; 15(2):241-7. PubMed ID: 7539235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoelectron microscopic studies on cytokeratins in human basal cell carcinoma.
    Habets JM; Tank B; Vuzevski VD; Brevé J; Van der Kwast T; Van Joost T
    Anticancer Res; 1989; 9(1):65-70. PubMed ID: 2468307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of cytokeratin 8 and inconsistent expression of cytokeratins 7 and 19 in human basal cell carcinoma.
    Habets JM; Tank B; Vuzevski VD; Brevé J; Stolz E; van Joost T
    Anticancer Res; 1988; 8(4):611-6. PubMed ID: 2460019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid basal cell epithelioma (BCE) possibly originates from the outer root sheath of the hair follicle.
    Asada M; Schaart FM; de Almeida HL; Korge B; Kurokawa I; Asada Y; Orfanos CE
    Acta Derm Venereol; 1993 Aug; 73(4):286-92. PubMed ID: 7506469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokeratin contents of basal cell carcinoma, epidermis overlying tumour, and associated stromal amyloidosis: an immunohistochemical study.
    Apaydin R; Gürbüz Y; Bayramgürler D; Bilen N
    Amyloid; 2005 Mar; 12(1):41-7. PubMed ID: 16076610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cytokeratin profile of canine epithelial skin tumours.
    Walter J
    J Comp Pathol; 2000 May; 122(4):278-87. PubMed ID: 10805981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The detection of basal cell determinants in human basal cell carcinomas using two different monoclonal antibodies.
    Habets JM; Tank B; Vuzevski VD; van Reede EC; Stolz E; van Joost T
    Acta Derm Venereol; 1987; 67(5):391-8. PubMed ID: 2448989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokeratin expression in trichilemmal carcinoma suggests differentiation towards follicular infundibulum.
    Kurokawa I; Senba Y; Nishimura K; Habe K; Hakamada A; Isoda K; Yamanaka K; Mizutani H; Tsubura A
    In Vivo; 2006; 20(5):583-5. PubMed ID: 17091763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokeratin profile in basal cell carcinoma.
    Alessi E; Venegoni L; Fanoni D; Berti E
    Am J Dermatopathol; 2008 Jun; 30(3):249-55. PubMed ID: 18496426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunomorphological features of cutaneous basal-cell carcinoma].
    Chuprov IN
    Vopr Onkol; 2008; 54(6):715-9. PubMed ID: 19241845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical characterization of the differentiation state of basal cell carcinomas with special interest for infiltrating relapsing tumors.
    Barbaud A; Simon M; Parache RM; Serre G
    Eur J Dermatol; 1998; 8(5):320-4. PubMed ID: 9683887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Patterns of keratin protein expression in basal cell, metatypical and squamous cell carcinoma of human skin].
    Karelina TV; Kazantseva IA
    Arkh Patol; 1991; 53(4):29-32. PubMed ID: 1714712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The evaluation of the relationship between malignancy grade and cytokeratin-10 accumulation in human skin squamous cell carcinoma].
    Osiecka BJ; Jeleń M; Marciniak Z
    Przegl Lek; 2001; 58(5):435-8. PubMed ID: 11603178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of insulin-like growth factor-I receptor in primary cutaneous carcinomas.
    Keehn CA; Saeed S; Bickle K; Khalil FK; Morgan MB
    J Cutan Pathol; 2004 May; 31(5):368-72. PubMed ID: 15059221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Specific characteristics of skin basal cell carcinoma invasion].
    Doĭkova NG; Chernyĭ AP; Chipysheva TA; Gel'shteĭn VI
    Arkh Patol; 2000; 62(3):29-33. PubMed ID: 10897434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokeratin subtyping in chordomas and the fetal notochord: an immunohistochemical analysis of aberrant expression.
    Naka T; Iwamoto Y; Shinohara N; Chuman H; Fukui M; Tsuneyoshi M
    Mod Pathol; 1997 Jun; 10(6):545-51. PubMed ID: 9195570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cytokeratin and vimentin expression in laryngeal squamous cell carcinoma].
    Cavicchi O; Cavazzuti PP; Caliceti U
    Acta Otorhinolaryngol Ital; 1996 Oct; 16(5):420-7. PubMed ID: 9199086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pinkus tumor may originate from intraepidermal eccrine ducts and proliferate in the dermis.
    Kurokawa I; Yokoyama T; Nishimura K; Hakamada A; Isoda K; Yamanaka K; Tsubura A; Mizutani H
    Oncol Rep; 2007 Jan; 17(1):49-54. PubMed ID: 17143477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical findings of sebaceous carcinoma and sebaceoma: retrieval of cytokeratin expression by a panel of anti-cytokeratin monoclonal antibodies.
    Ansai S; Arase S; Kawana S; Kimura T
    J Dermatol; 2011 Oct; 38(10):951-8. PubMed ID: 21592202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.